AR
Ankit Ramesh Savaliya
About Ankit Ramesh Savaliya
Data last updated:
Ankit Ramesh Savaliya has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Almon Healthcare Private Limited and Aptive Pharma Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Almon Healthcare Private Limited at ₹38.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Jun 2022 | 2022 | ₹38.26 Cr (FY 2025) | Active | |
| Director | 24 Jul 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankit Ramesh Savaliya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankit Ramesh Savaliya
Ankit Ramesh Savaliya has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Almon Healthcare Private Limited and Aptive Pharma Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Almon Healthcare Private Limited at ₹38.26 Cr (FY 2025).
Ankit Ramesh Savaliya is associated with 2 companies as Director, including Almon Healthcare Private Limited (₹38.26 Cr), Aptive Pharma Private Limited.
Ankit Ramesh Savaliya has expertise in Healthcare, General Business.
Ankit Ramesh Savaliya has 4 years in corporate governance.
By reported revenue, the largest current company of Ankit Ramesh Savaliya is Almon Healthcare Private Limited, with revenue of ₹38.26 Cr (FY 2025).
Ankit Ramesh Savaliya currently holds positions at 2 companies: Almon Healthcare Private Limited (₹38.26 Cr), Aptive Pharma Private Limited.